Page last updated: 2024-08-16

tibolone and Atherogenesis

tibolone has been researched along with Atherogenesis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bjarnason, NH	1
Clarkson, TB	1
Bots, ML; Evans, GW; Grobbee, DE; Helmond, FA; McBride, KH; Paskett, ED; Riley, W	1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vlachou, SA	1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA	1
Campisi, R; Marengo, FD	1
Bayram, M; Kabakci, N; Kalender, H; Kisa, U; Ozer, G; Ozkan, Y	1
Christodoulakos, GE; Creatsa, MG; Economou, EV; Kalligerou, I; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Siasou, Z	1

Reviews

1 review(s) available for tibolone and Atherogenesis

Article	Year
Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovascular drug reviews, 2007,Summer, Volume: 25, Issue:2 Topics: Animals; Atherosclerosis; Blood Coagulation; Cardiovascular System; Coronary Disease; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Tunica Intima	2007

Trials

4 trial(s) available for tibolone and Atherogenesis

Article	Year
The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study. European heart journal, 2006, Volume: 27, Issue:6 Topics: Aged; Atherosclerosis; Double-Blind Method; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Treatment Outcome; Tunica Intima; Tunica Media	2006
Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:4 Topics: Adult; Androgen Antagonists; Atherosclerosis; Climacteric; Female; Hormones; Humans; Lipids; Lipoproteins; Middle Aged; Norpregnenes; Postmenopause	2006
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis, 2007, Volume: 193, Issue:1 Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2007
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:2 Topics: Adipokines; Adiponectin; Adult; Apoptosis; Atherosclerosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fas Ligand Protein; fas Receptor; Female; Greece; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Resistin; Selective Estrogen Receptor Modulators	2008

Other Studies

3 other study(ies) available for tibolone and Atherogenesis

Article	Year
Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Danish medical bulletin, 2005, Volume: 52, Issue:2 Topics: Animals; Atherosclerosis; Bone and Bones; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2005
Does tibolone exacerbate atherosclerosis? European heart journal, 2006, Volume: 27, Issue:6 Topics: Atherosclerosis; Estrogen Receptor Modulators; Female; Humans; Norpregnenes	2006
The effects of raloxifene and tibolone on homocysteine and vascular histopathological changes. Clinical and experimental medicine, 2007, Volume: 7, Issue:4 Topics: Animals; Atherosclerosis; Carotid Arteries; Estrogen Replacement Therapy; Female; Folic Acid; Homocysteine; Norpregnenes; Raloxifene Hydrochloride; Rats; Rats, Wistar; Vitamin B 12	2007